Patents Assigned to The State of Israel, Ministry of Agriculture & Rural Development, Kimron Veterinary Institute
  • Publication number: 20220184153
    Abstract: A method of treating or preventing mastitis in a bovine animal comprising administering to the animal a therapeutically effective amount of particular microbes thereby treating or preventing mastitis in the animal.
    Type: Application
    Filed: March 24, 2020
    Publication date: June 16, 2022
    Applicants: The State of Israel, Ministry of Agriculture&Rural Development, Agricltural Research Oganization(ARO, The State of Israel, Ministry of Agriculture & Rural Development, Kimron Veterinary Institute
    Inventors: Moshe SHEMESH, Shlomo BLUM
  • Patent number: 10041131
    Abstract: An isolated polynucleotide is disclosed which comprises a nucleic acid sequence of a Brucella phage, the nucleic acid sequence being specific to the Brucella phage and comprising a sequence selected from the group consisting of SEQ ID NOs: 387-393. An exemplary polynucleotide sequence is one which comprises at least 100 consecutive nucleotides of a nucleic acid sequence as set forth in SEQ ID NO: 396. Uses of such sequences are further disclosed.
    Type: Grant
    Filed: May 11, 2014
    Date of Patent: August 7, 2018
    Assignee: The State of Israel, Ministry of Agriculture & Rural Development, Kimron Veterinary Institute
    Inventors: Menachem Banai, Valeria Strada, Svetlana Bardenstein, Itzhak Ben-Asouli, Farhat Osman
  • Patent number: 9730998
    Abstract: The present invention relates to vaccine compositions comprising attenuated strain of Tilapia Lake Virus (TiLV) for protecting tilapia fish against infection by (TiLV). The invention also relates to methods for using the vaccines to protect tilapines from TiLV-induced disease.
    Type: Grant
    Filed: February 11, 2015
    Date of Patent: August 15, 2017
    Assignees: The State of Israel, Ministry of Agriculture & Rural Development, Kimron Veterinary Institute, Ramot at Tel-Aviv University Ltd.
    Inventors: Eran Bacharach, Avi Eldar
  • Publication number: 20140248607
    Abstract: An isolated polynucleotide is disclosed which comprises a nucleic acid sequence of a Brucella phage, the nucleic acid sequence being specific to the Brucella phage and comprising a sequence selected from the group consisting of SEQ ID NOs: 387-393. An exemplary polynucleotide sequence is one which comprises at least 100 consecutive nucleotides of a nucleic acid sequence as set forth in SEQ ID NO: 396. Uses of such sequences are further disclosed.
    Type: Application
    Filed: May 11, 2014
    Publication date: September 4, 2014
    Applicant: The State of Israel, Ministry of Agriculture & Rural Development, Kimron Veterinary Institute
    Inventors: Menachem BANAI, Valeria Strada, Svetlana Bardenstein, Itzhak Ben-Asouli, Farhat Osman
  • Patent number: 8722411
    Abstract: An isolated polynucleotide is disclosed which comprises a nucleic acid sequence of a Brucella phage, the nucleic acid sequence being specific to the Brucella phage and comprising a sequence selected from the group consisting of SEQ ID NOs: 387-393. An exemplary polynucleotide sequence is one which comprises at least 100 consecutive nucleotides of a nucleic acid sequence as set forth in SEQ ID NO: 396. Uses of such sequences are further disclosed.
    Type: Grant
    Filed: October 7, 2010
    Date of Patent: May 13, 2014
    Assignee: The State of Israel, Ministry of Agriculture & Rural Development, Kimron Veterinary Institute
    Inventors: Menachem Banai, Valeria Strada, Svetlana Bardenstein, Itzhak Ben-Asouli, Farhat Osman